Categories: New Launches

Cipla launches novel “5 in 1” anti-ageing skin care product Cutisera™ developed by Stempeutics

India, Mumbai, December 09, 2015: Cipla Ltd, a global pharmaceutical company announced today that it has launched a novel “5 in 1” anti-ageing skin care product Cutisera™ developed by Stempeutics. Cutisera™ has been developed using bio-active factors derived from human adult stem cells to enhance the rejuvenation of ageing skin. The active ingredients have been tested for in vitro and in vivo efficacy. The product has been dermatologically tested with human volunteers with features of ageing skin over a period of 3 months, wherein the product was applied twice a day. This human study has demonstrated Cutisera™’s effectiveness as a powerful and yet soothing anti-ageing skin care product suitable for all skin types of Indian origin. The formulated product does not contain any stem cells.

Commenting on the Cutisera™ launch, Mr Chandru Chawla, Head of Cipla New Ventures said, “We are excited to launch Cutisera™ the next generation bio-engineered skin care product. As we age and get exposed to environmental stressors, the production of human growth factors within skin is depleted, giving rise to features of ageing skin. By re-introducing these factors through daily application of Cutisera™, damaged skin cells are repaired resulting in rejuvenation of the skin.”

“We are pleased to market Cutisera™ through our JV partner Cipla”, said Mr BN Manohar CEO of Stempeutics. “Already physician and consumer interest in Cutisera™ has been high. Cutisera™ has been developed using a unique & proprietary patent-pending technology that produces stable key ingredients containing growth factors and cytokines in specified amounts – batch after batch. This results in a consistent high quality product bench marked globally.”

Dr Jaideep Gogtay, Chief Medical Officer of Cipla said, “Improved technology and increased awareness is making people more concerned about their skin, this is driving them to look for skincare products that will not only slowdown the aging process but will also maintain their youthful look for a longer period. It is important to first understand what causes aging and then dealing with the underlying causes. Cutisera™ exactly does the same. It assists the body’s natural biological repair processes to treat damaged skin and prevent further damage.”

Corporate Comm India(CCI Newswire)

The Pharma Times News Bureau

Recent Posts

World Diabetes Day Survey: Diabetologists and Endocrinologists demand for AI-Based Training and Upskilling in Diabetes Care

 A striking 90% of the 3000 Diabetologists and Endocrinologists surveyed, emphasised the importance of continuous…

17 hours ago

Doctors warn diabetes patients about risk of smoking

People who smoke are also at much higher risk of developing diabetes compared to non-smokers…

2 days ago

CPHI & PMEC India Expo: Encouraging affordable solutions in India’s march towards a $130 Billion Pharma Market by 2030

17th edition of CPHI& PMEC India Expo to be held from 26th November-28thNovember 2024, at the India…

2 days ago

Sringeri Sharada Equitas Hospital Revolutionizing Cancer Care with the Launch of Low-cost, High Quality Radiation Therapy

The launch signifies Equitas’ redefined commitment to bring world-class cancer radiation therapy accessible to all.…

3 days ago